Literature DB >> 6385900

Insulin and glucagon infusion in the treatment of liver failure.

J B Jaspan, R L Landau, J Schneider.   

Abstract

In an attempt to improve liver function and promote hepatic regeneration in a patient with severe liver injury, insulin alone or insulin and glucagon were administered by constant peripheral venous infusion during a 61-day period. The response, as assessed by a broad spectrum of hepato-cellular function tests, including synthetic, detoxification, bile metabolism, and microsomal enzyme function, and also histological evidence, indicated a beneficial effect. Continuous insulin and glucagon infusion merits further evaluation in the treatment of some forms of hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385900

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  3 in total

1.  Insulin and glucagon therapy of acute hepatic failure.

Authors:  K Fujiwara; I Ogata; Y Sato; T Tomiya; Y Ohta; Y Oka; S Nagoshi; S Yamada; N Masaki; K Takatsuki
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis.

Authors:  K Okita; S Matsuda; T Hanta; M Yasunaga; K Sanuki; T Takemoto
Journal:  Gastroenterol Jpn       Date:  1987-10

3.  Insulin and glucagon levels in fulminant hepatic failure in man.

Authors:  F Fiaccadori; G Pedretti; C Ferrari; P Pizzaferri; O Riggio; N Orlandi; A Pezzarossa
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.